Southern Sky CBD Pastilles
| Location | Qty | Batch | Expiration Date |
|---|---|---|---|
| Alfie-8B | 72.0000 | PP25L09 | 2026-11-30 |
| Alfie-10A | 14.0000 | PP25L09 | 2026-11-30 |
| Alfie-10D | 72.0000 | PP25L09 | 2026-11-30 |
Downloads
Description
Retail Price: $149.00
Size: 60 units
Cannabinoids: 110 mg CBD / 20 mg CBG per pastille
Total Terpenes: 2.0% w/w
% of Total Terpenes: Limonene 0.60% w/w, Caryophyllene 0.60% w/w, Pinene 0.80% w/w
Flavour: Blueberry
Extraction Method: CO2 extraction
Carrier Oil: MCT Oil
Dietary: Vegan
Reported Uses & Effects
Based on patient and doctor testimonials, this cultivar may be used to treat the following conditions:
- Anxiety & Depression
- Chronic Pain Conditions
- Multiple Sclerosis
- Epilepsy
- Chemotherapy-induced nausea and vomiting (CINV)
- Inflammatory Bowel Disease
- Inflammatory Related Conditions
- Parkinsons
Patients reported the following uses:
- Pain Relief
- Relaxation
- Mood Enhancement
Product Description
This cannabidiol-forward formulation delivers 110 mg of CBD and 20 mg of CBG per pastille, supported by a 2.0% total terpene profile. The formulation is shaped by Limonene (0.60% of total terpenes), beta-Caryophyllene (0.60% of total terpenes) and Pinene (0.80% of total terpenes), creating a balanced chemotype with a mild uplift and a steady functional profile across daytime and evening use.
Southern Sky CBD+ Pastilles are manufactured in Australia using a pectin base with MCT oil as the carrier and CO2 extracted cannabinoids. Small-batch production ensures precise cannabinoid distribution, stable texture, and dependable terpene expression across all 60 units, reflecting Southern Sky’s emphasis on formulation consistency.
Anecdotally, patients describe a clear, balanced effect with gentle mood elevation, improved focus and a generally settling influence without sedation. Prescribers commonly select this profile for patients presenting with anxiety, low mood, inflammatory symptoms, behavioural dysregulation or sleep disturbance, with reports of steady cognitive function and a calm, moderated emotional response.
As with all oral cannabinoid products, the slower onset and extended duration should be considered when determining timing and dose. Initiating therapy with gradual titration is generally recommended to identify individual response patterns.
Ingesting cannabis compared to inhalation
Onset of action when ingesting cannabis oil can take 60-180 minutes, with effects lasting 6-8 hours. When cannabis is inhaled, the effects have a rapid onset of action in 5-10 minutes, with a duration of 2-4 hours.
It is recommended to take the same dose under the same conditions each day to accurately gauge the effects of cannabis oil. Variation of onset and duration is due to several factors, including cannabinoid diversity, potency, and quantity of cannabis oil consumed.
Individual patient variables which may influence the effects of ingested cannabis oil are time of day consumed, patient tolerance, metabolism, and empty or full stomach.
Dosage Recommendation
